OpioidCrisis

Canadian Supreme Court Greenlights Class Action Against Opioid Makers in British Columbia

24 days ago

In a landmark ruling, the Supreme Court of Canada has ruled that British Columbia can proceed with a class action lawsuit targeting opioid manufacturers. This groundbreaking decision, announced on November 29, 2024, comes amidst a national crisis concerning opioid-related overdoses and deaths that have plagued Canada for several years. The court's ruling signifies a pivotal moment in the fight against the opioid epidemic, allowing the province to hold pharmaceutical companies accountable for their alleged roles in fueling the crisis.

Indivior Secures Financial Stability with Debt Refinancing Deal

2 months ago

Indivior, the global pharmaceutical company known for its treatments for addiction and mental health disorders, has successfully extended the maturity of its debt through a strategic refinancing of its term loan. This maneuver is aimed at enhancing the company's financial flexibility and overall stability as it navigates the post-pandemic recovery landscape.

Revolutionizing Overdose Prevention: The Potential of a Fentanyl Vaccine

2 months ago

The ongoing battle against the opioid epidemic, particularly the surge of fentanyl-related overdoses in recent years, is taking a hopeful turn with the development of a groundbreaking vaccine. Researchers are excited about the possibilities of a vaccine that could immunize individuals against the harmful effects of fentanyl, potentially saving thousands of lives. This innovative approach aims not only to reduce the risk of overdose but also to change the landscape of addiction treatment.

The Race Against Time: Can a Fentanyl Vaccine Curb the Opioid Crisis?

2 months ago

In a groundbreaking development in the fight against the escalating opioid epidemic in the United States, researchers are optimistic about the potential of a novel fentanyl vaccine. This innovative approach could revolutionize addiction treatment and significantly reduce the staggering number of overdose deaths attributed to this powerful synthetic opioid, which has claimed thousands of lives each year.

The Rise of Kratom: Navigating a $1 Billion Legal Gray Area

3 months ago

Kratom has been one of the most controversial plants of interest in recent years, morphing into a billion-dollar industry inside a comfortable legal gray area. Once a Southeast Asian botanical, kratom has transitioned from a simple herbal remedy into a modern-day health trend with the increasing fascination of many consumers, health advocates, and regulators.